Spandana Sphoorty Secures ₹485 Crore to Strengthen Capital

Spandana Sphoorty Financial Ltd has approved the allotment of 4,85,000 Non-Convertible Debentures (NCDs) for a total of ₹485 crore through a private placement. This secured debt issuance is designed to bolster the company's capital structure and financial resources.

Funding Approval Details

Spandana Sphoorty Financial Ltd announced on April 28, 2026, that it had approved the allotment of 4,85,000 Non-Convertible Debentures (NCDs). These debentures are described as listed, rated, senior, secured, redeemable, and non-convertible, collectively raising ₹485 crore. The private placement of these debt instruments represents a strategic move to enhance the company's capital base and financial liquidity.

Strategic Importance of Capital Boost

For a microfinance institution like Spandana Sphoorty, a strong capital structure is essential for meeting regulatory requirements and funding its lending activities. This fundraising occurs at a critical time as the company works to overcome past asset quality challenges and re-establish its growth momentum. This demonstrates continued access to debt markets, a primary funding source for NBFCs, enabling them to serve their customer base effectively.

Financial Context and Past Performance

Spandana Sphoorty, a prominent Non-Banking Financial Company-Microfinance Institution (NBFC-MFI), has been prioritizing the cleanup of its loan book and the strengthening of its financial position. The company reported significant write-offs in FY2025 and the first nine months of FY2026 due to asset quality pressures. This led to a notable contraction in its Assets Under Management (AUM), which decreased from ₹11,973 crore in March 2024 to ₹3,948 crore by December 2025. To support its capital base, Spandana Sphoorty previously approved the issuance of secured NCDs worth ₹415 crore in December 2025 and raised ₹4,079 crore in external funding during fiscal 2025. The company has also navigated regulatory matters, settling a disclosure violation case with the Securities and Exchange Board of India (SEBI) in August 2024 for ₹38 lakh and a prior settlement in October 2022 for ₹25 lakh.

Impact of the New Capital

The ₹485 crore infusion is set to enhance Spandana Sphoorty's capital base, potentially improving its Capital to Risk Weighted Assets Ratio (CRAR). Access to diversified debt instruments like NCDs offers greater flexibility compared to relying solely on bank loans. The increased capital can support renewed disbursement strategies and a focus on originating healthier loan portfolios. Furthermore, a successful debt raising can signal ongoing investor confidence in the company's management and its long-term prospects.

Key Risks and Challenges

Managing the interest costs and repayment obligations associated with the new debt issuance will be crucial for Spandana Sphoorty. The company also faces the risk of rising interest rates, which could increase its borrowing expenses. Continued diligence in underwriting standards and collections is vital to prevent a recurrence of past asset quality issues. While waivers have been obtained for some past covenant breaches, ongoing adherence to loan covenants remains critical for financial stability.

Microfinance Sector Landscape

Spandana Sphoorty operates within a competitive microfinance sector alongside peers such as CreditAccess Grameen and Fusion Micro Finance. The sector has experienced an overall portfolio contraction, yet NBFC-MFIs maintain a dominant market share. Funding availability remains robust for the sector, with debt funding notably increasing.

Performance Snapshot

The company's consolidated cost-to-income ratio rose to 157.5% in the first nine months of FY2026, a significant increase from 62.1% in FY2025, impacting operating efficiency. Spandana Sphoorty reported substantial write-offs, totaling ₹1,274 crore in the first nine months of FY2026 and ₹1,618 crore in FY2025 at the consolidated level.

Investor Outlook: Key Factors

Investors will be closely monitoring the pace and quality of new loan disbursals following the capital infusion. Key metrics such as Portfolio at Risk (PAR) and Gross Stage 3 (GS3) delinquency ratios for newly originated portfolios will be under scrutiny. Tracking Spandana Sphoorty's ability to manage its borrowing costs effectively and restore profitability amidst operational improvements and asset quality management will be essential. The company's overall strategy for managing debt levels and its capital structure will also be a significant focus.